Zobrazeno 1 - 10
of 292
pro vyhledávání: '"Magyarics, Z."'
Publikováno v:
In Value in Health June 2023 26(6) Supplement:S103-S103
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Xu, Yaqi1,2 (AUTHOR) yaqi.xu@mail.ccmu.edu.cn, Gao, Ran1,2 (AUTHOR) gaoran@mail.ccmu.edu.cn, Zhang, Min1,2 (AUTHOR) zhangmin@mail.ccmu.edu.cn, Zeng, Qi1,2 (AUTHOR) zengqi2022@mail.ccmu.edu.cn, Zhu, Gaizhi1,2 (AUTHOR) 112020010272@ccmu.edu.cn, Qiu, Jinming1,2 (AUTHOR) xqxxps@mail.ccmu.edu.cn, Su, Wenting1,2 (AUTHOR) wtsu@ccmu.edu.cn, Wang, Renxi1,2 (AUTHOR) wtsu@ccmu.edu.cn
Publikováno v:
International Journal of Molecular Sciences. Jul2024, Vol. 25 Issue 13, p7253. 13p.
Autor:
Fabiano, Abigail R.1 (AUTHOR), Robbins, Spencer C.1 (AUTHOR), Knoblauch, Samantha V.1 (AUTHOR), Rowland, Schyler J.1 (AUTHOR), Dombroski, Jenna A.1 (AUTHOR), King, Michael R.1 (AUTHOR) mike.king@rice.edu
Publikováno v:
Communications Biology. 6/1/2024, Vol. 7 Issue 1, p1-15. 15p.
Autor:
Kabak E; Previously Arsanis Biosciences GmbH, Vienna, Austria.; Independent Researcher, Vienna, Austria., Hudcova J; Lahey Hospital and Medical Center, Burlington, MA, USA., Magyarics Z; X4 Pharmaceuticals Inc, Cambridge, MA, USA. zoltan.magyarics@x4pharma.com.; Wilhelm-Weber-Weg 4/3/2, A-1110, Wien, Austria. zoltan.magyarics@x4pharma.com., Stulik L; X4 Pharmaceuticals Inc, Cambridge, MA, USA., Goggin M; Lahey Hospital and Medical Center, Burlington, MA, USA., Szijártó V; CEBINA (Central European Biotech Incubator and Accelerator) GmbH, Vienna, Austria., Nagy E; CEBINA (Central European Biotech Incubator and Accelerator) GmbH, Vienna, Austria., Stevens C; Previously Arsanis Biosciences GmbH, Vienna, Austria.; Independent Researcher, Vienna, Austria.
Publikováno v:
BMC infectious diseases [BMC Infect Dis] 2019 Aug 29; Vol. 19 (1), pp. 756. Date of Electronic Publication: 2019 Aug 29.
Autor:
Magyarics Z; Arsanis Biosciences GmbH, Vienna, Austria Zoltan.Magyarics@x4pharma.com bernd.jilma@meduniwien.ac.at., Leslie F; Arsanis, Inc., Waltham, Massachusetts USA., Bartko J; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria., Rouha H; Arsanis Biosciences GmbH, Vienna, Austria., Luperchio S; Arsanis, Inc., Waltham, Massachusetts USA., Schörgenhofer C; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria., Schwameis M; Department of Emergency Medicine, Medical University of Vienna, Vienna, Austria., Derhaschnig U; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria., Lagler H; Department of Internal Medicine I, Division of Infectious Diseases and Tropical Medicine, Medical University of Vienna, Vienna, Austria., Stiebellehner L; Department of Internal Medicine II, Division of Pulmonology, Medical University of Vienna, Vienna, Austria., Firbas C; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria., Weber S; Arsanis Biosciences GmbH, Vienna, Austria., Campanaro E; Arsanis, Inc., Waltham, Massachusetts USA., Jilma B; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria Zoltan.Magyarics@x4pharma.com bernd.jilma@meduniwien.ac.at., Nagy E; EveliQure Biotechnologies GmbH, Vienna, Austria., Stevens C; Arsanis, Inc., Waltham, Massachusetts USA.
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2019 Jul 25; Vol. 63 (8). Date of Electronic Publication: 2019 Jul 25 (Print Publication: 2019).
Autor:
Ingmer H; Department of Veterinary and Animal Science, University of Copenhagen, Copenhagen, Denmark., Leisner JJ; Department of Veterinary and Animal Science, University of Copenhagen, Copenhagen, Denmark., Fulaz S; Department of Veterinary and Animal Science, University of Copenhagen, Copenhagen, Denmark.
Publikováno v:
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica [APMIS] 2024 Aug 27. Date of Electronic Publication: 2024 Aug 27.
Autor:
Badarau A; a Arsanis Biosciences , Campus Vienna Biocenter, Vienna , Austria., Rouha H; a Arsanis Biosciences , Campus Vienna Biocenter, Vienna , Austria., Malafa S; a Arsanis Biosciences , Campus Vienna Biocenter, Vienna , Austria., Battles MB; b Adimab LLC , Lebanon , NH , USA., Walker L; b Adimab LLC , Lebanon , NH , USA., Nielson N; b Adimab LLC , Lebanon , NH , USA., Dolezilkova I; a Arsanis Biosciences , Campus Vienna Biocenter, Vienna , Austria., Teubenbacher A; a Arsanis Biosciences , Campus Vienna Biocenter, Vienna , Austria., Banerjee S; a Arsanis Biosciences , Campus Vienna Biocenter, Vienna , Austria., Maierhofer B; a Arsanis Biosciences , Campus Vienna Biocenter, Vienna , Austria., Weber S; a Arsanis Biosciences , Campus Vienna Biocenter, Vienna , Austria., Stulik L; a Arsanis Biosciences , Campus Vienna Biocenter, Vienna , Austria., Logan DT; c SARomics Biostructures AB , Medicon Village, Lund , Sweden., Welin M; c SARomics Biostructures AB , Medicon Village, Lund , Sweden., Mirkina I; a Arsanis Biosciences , Campus Vienna Biocenter, Vienna , Austria., Pleban C; a Arsanis Biosciences , Campus Vienna Biocenter, Vienna , Austria., Zauner G; a Arsanis Biosciences , Campus Vienna Biocenter, Vienna , Austria., Gross K; a Arsanis Biosciences , Campus Vienna Biocenter, Vienna , Austria., Jägerhofer M; a Arsanis Biosciences , Campus Vienna Biocenter, Vienna , Austria., Magyarics Z; a Arsanis Biosciences , Campus Vienna Biocenter, Vienna , Austria., Nagy E; a Arsanis Biosciences , Campus Vienna Biocenter, Vienna , Austria.
Publikováno v:
MAbs [MAbs] 2016 Oct; Vol. 8 (7), pp. 1347-1360. Date of Electronic Publication: 2016 Jul 28.
Autor:
Szijártó V; Arsanis Biosciences GmbH, Vienna, Austria., Guachalla LM; Arsanis Biosciences GmbH, Vienna, Austria., Visram ZC; Arsanis Biosciences GmbH, Vienna, Austria., Hartl K; Arsanis Biosciences GmbH, Vienna, Austria., Varga C; Arsanis Biosciences GmbH, Vienna, Austria., Mirkina I; Arsanis Biosciences GmbH, Vienna, Austria., Zmajkovic J; Arsanis Biosciences GmbH, Vienna, Austria., Badarau A; Arsanis Biosciences GmbH, Vienna, Austria., Zauner G; Arsanis Biosciences GmbH, Vienna, Austria., Pleban C; Arsanis Biosciences GmbH, Vienna, Austria., Magyarics Z; Arsanis Biosciences GmbH, Vienna, Austria., Nagy E; Arsanis Biosciences GmbH, Vienna, Austria., Nagy G; Arsanis Biosciences GmbH, Vienna, Austria gabor.nagy@arsanis.com.
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2015; Vol. 59 (6), pp. 3109-16. Date of Electronic Publication: 2015 Mar 16.
Autor:
Rouha H; a Arsanis Biosciences ; Vienna , Austria., Badarau A, Visram ZC, Battles MB, Prinz B, Magyarics Z, Nagy G, Mirkina I, Stulik L, Zerbs M, Jägerhofer M, Maierhofer B, Teubenbacher A, Dolezilkova I, Gross K, Banerjee S, Zauner G, Malafa S, Zmajkovic J, Maier S, Mabry R, Krauland E, Wittrup KD, Gerngross TU, Nagy E
Publikováno v:
MAbs [MAbs] 2015; Vol. 7 (1), pp. 243-54.